The classification of breast cancer tumours by gene expression analysis into intrinsic subtypes (Luminal A, Luminal B, human epidermal growth factor receptor 2-enriched [HER2-E], and Basal-like), is well-established1–3. This evidence concerns the gene ERBB2 and breast cancer.